• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在重症监护环境及其他环境中过度使用应激性溃疡预防药物。

Overuse of stress ulcer prophylaxis in the critical care setting and beyond.

机构信息

Department of Internal Medicine Residency Program, Annenberg Conference Center, Lankenau Hospital, Wynnewood, PA 19096, USA.

出版信息

J Crit Care. 2010 Jun;25(2):214-20. doi: 10.1016/j.jcrc.2009.05.014. Epub 2009 Aug 15.

DOI:10.1016/j.jcrc.2009.05.014
PMID:19683892
Abstract

BACKGROUND

Patients admitted to the intensive care unit (ICU) are susceptible to stress ulcers. We hypothesize that despite recommendations, stress ulcer prophylaxis (SUP) is still overused in the ICU and often continued after resolution of risk factors for bleeding.

METHODS

We retrospectively studied all ICU admissions for 4 months. Risk factors for stress ulcer bleeding were collected. Patients were categorized into 4 groups: (1) >or=1 major risk factor; (2) >or=1 minor risk factors; (3) no risk factors; (4) preadmission use of acid-suppressive medication. The rate of SUP was calculated by group during ICU stay, on transfer from the ICU, and at hospital discharge.

RESULTS

Two hundred ten patients were studied. Of all the ICU admissions, 87.1% received SUP. Among patients with no risk factors, 68.1% were placed on prophylaxis on ICU admission; 60.4% continued on treatment upon transfer from the ICU; 31.0% were discharged home on an agent without a new indication.

CONCLUSIONS

Although judicious use of SUP in high-risk patients can decrease the incidence of gastrointestinal bleeding, inappropriate use may increase drug reactions, unnecessary hospital costs, and personal monetary burden. Our findings argue for improvement measures to reduce initial inpatient overuse of SUP and to prompt discontinuation before hospital discharge.

摘要

背景

入住重症监护病房(ICU)的患者易发生应激性溃疡。我们假设,尽管有相关建议,但 ICU 中应激性溃疡预防(SUP)仍被过度使用,且常在出血风险因素消除后仍继续使用。

方法

我们对 4 个月内所有 ICU 住院患者进行了回顾性研究。收集了应激性溃疡出血的风险因素。患者分为 4 组:(1)有≥1 个主要风险因素;(2)有≥1 个次要风险因素;(3)无风险因素;(4)入院前使用抑酸药物。在 ICU 住院期间、从 ICU 转出时和出院时,按组计算 SUP 的使用率。

结果

研究了 210 例患者。所有 ICU 住院患者中,87.1%接受了 SUP。无风险因素的患者中,68.1%在 ICU 入院时开始预防治疗;60.4%在从 ICU 转出时继续治疗;31.0%出院时带药回家,而无新指征。

结论

尽管在高危患者中合理使用 SUP 可降低胃肠道出血的发生率,但不适当的使用可能会增加药物反应、不必要的医院费用和个人经济负担。我们的研究结果表明,需要采取改进措施,以减少初始住院患者 SUP 的过度使用,并在出院前及时停药。

相似文献

1
Overuse of stress ulcer prophylaxis in the critical care setting and beyond.在重症监护环境及其他环境中过度使用应激性溃疡预防药物。
J Crit Care. 2010 Jun;25(2):214-20. doi: 10.1016/j.jcrc.2009.05.014. Epub 2009 Aug 15.
2
Medication reconciliation effect on prolonged inpatient stress ulcer prophylaxis.药物重整对延长住院患者应激性溃疡预防的影响。
Ann Pharmacother. 2008 Jul;42(7):940-6. doi: 10.1345/aph.1L123. Epub 2008 Jun 24.
3
Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients.非重症监护病房住院患者应激性溃疡预防措施不当使用的程度及经济影响。
Am J Gastroenterol. 2006 Oct;101(10):2200-5. doi: 10.1111/j.1572-0241.2006.00839.x. Epub 2006 Sep 4.
4
Inappropriate continuation of stress ulcer prophylaxis beyond the intensive care setting.不适当的在重症监护环境之外持续应激性溃疡预防。
Crit Care Resusc. 2013 Jun;15(2):147-51.
5
Frequency of inappropriate continuation of acid suppressive therapy after discharge in patients who began therapy in the surgical intensive care unit.在外科重症监护病房开始接受治疗的患者出院后不适当继续进行抑酸治疗的频率。
Pharmacotherapy. 2008 Aug;28(8):968-76. doi: 10.1592/phco.28.8.968.
6
Inappropriate continuation of stress ulcer prophylactic therapy after discharge.出院后不适当继续进行应激性溃疡预防性治疗。
Ann Pharmacother. 2007 Oct;41(10):1611-6. doi: 10.1345/aph.1K227. Epub 2007 Sep 11.
7
Stress ulcer prophylaxis: reducing non-indicated prescribing after hospital discharge.应激性溃疡预防:减少出院后的非指征性处方。
Ann Pharmacother. 2010 Oct;44(10):1565-71. doi: 10.1345/aph.1P167. Epub 2010 Sep 14.
8
Stress ulcer prophylaxis in the intensive care unit: an international survey of 97 units in 11 countries.重症监护病房应激性溃疡的预防:对11个国家97个单位的国际调查。
Acta Anaesthesiol Scand. 2015 May;59(5):576-85. doi: 10.1111/aas.12508.
9
Stress ulcer prophylaxis for non-critically ill patients on a teaching service.对教学医院中病情不严重患者的应激性溃疡预防措施。
J Eval Clin Pract. 2007 Oct;13(5):716-21. doi: 10.1111/j.1365-2753.2006.00742.x.
10
Patterns of use of prophylaxis for stress-related mucosal disease in patients admitted to the intensive care unit.重症监护病房患者应激性黏膜病变预防措施的使用模式。
J Intensive Care Med. 2014 Mar-Apr;29(2):96-103. doi: 10.1177/0885066612453542. Epub 2012 Jul 10.

引用本文的文献

1
Risk Factors for Stress-related Upper Gastrointestinal Bleeding: More Than a Gut Feeling.应激相关上消化道出血的危险因素:不止是一种直觉。
Am J Respir Crit Care Med. 2025 Sep;211(9):1547-1548. doi: 10.1164/rccm.202504-0977ED.
2
Optimizing stress ulcer prophylaxis practices and reducing associated costs in intensive care units: a non-randomized controlled study.优化重症监护病房应激性溃疡预防措施并降低相关成本:一项非随机对照研究。
J Pharm Pharm Sci. 2025 Apr 10;28:14295. doi: 10.3389/jpps.2025.14295. eCollection 2025.
3
Ensuring guideline adherence and cost savings in stress ulcer prophylaxis practices in the intensive care unit: a pre-post education study.
确保重症监护病房应激性溃疡预防措施符合指南要求并节省成本:一项教育前后对照研究。
J Pharm Pharm Sci. 2025 Mar 4;28:14067. doi: 10.3389/jpps.2025.14067. eCollection 2025.
4
Effectiveness of a Pharmacist-Led Intervention to Reduce Acid Suppression Therapy for Stress Ulcer Prophylaxis in ICUs in China: A Multicenter, Stepped-Wedge, Cluster-Randomized Controlled Trial.药师主导的干预措施在中国重症监护病房减少应激性溃疡预防的抑酸治疗的有效性:一项多中心、阶梯式楔形、整群随机对照试验
Crit Care Med. 2025 Jan 31;53(4):e805-16. doi: 10.1097/CCM.0000000000006589.
5
Appropriateness of proton pump inhibitors use in noncritically ill hospitalized children in a tertiary hospital in Saudi Arabia.沙特阿拉伯一家三级医院非危重症住院儿童使用质子泵抑制剂的合理性。
Saudi Pharm J. 2023 Sep;31(9):101723. doi: 10.1016/j.jsps.2023.101723. Epub 2023 Jul 31.
6
Medication-related problems in critical care survivors: a systematic review.重症监护幸存者的药物相关问题:系统评价。
Eur J Hosp Pharm. 2023 Sep;30(5):250-256. doi: 10.1136/ejhpharm-2023-003715. Epub 2023 May 4.
7
Impact of Stress Ulcer Prophylaxis Discontinuation Guidance in Mechanically Ventilated, Critically Ill Patients: A Pre-Post Cohort Study.应激性溃疡预防停药指导对机械通气重症患者的影响:一项前后队列研究
Hosp Pharm. 2022 Aug;57(4):510-517. doi: 10.1177/00185787211061371. Epub 2021 Dec 7.
8
Stress ulcer prophylaxis use in critical care units at public hospitals in Johannesburg, South Africa.南非约翰内斯堡公立医院重症监护病房应激性溃疡预防措施的使用情况。
South Afr J Crit Care. 2021 Mar 17;37(1). doi: 10.7196/SAJCC.2021.v37i1.439. eCollection 2021.
9
Pharmacist-Led Intervention on the Inappropriate Use of Stress Ulcer Prophylaxis Pharmacotherapy in Intensive Care Units: A Systematic review.药剂师主导的重症监护病房应激性溃疡预防药物治疗不当使用干预措施:一项系统评价
Front Pharmacol. 2021 Oct 25;12:741724. doi: 10.3389/fphar.2021.741724. eCollection 2021.
10
Appropriateness of Acid-suppressing Agents for Stress Ulcer Prophylaxis in Non-intensive Care Unit Setting in Saudi Arabia.沙特阿拉伯非重症监护病房环境中使用抑酸剂进行应激性溃疡预防的适宜性
J Pharm Bioallied Sci. 2019 Jan-Mar;11(1):96-101. doi: 10.4103/jpbs.JPBS_173_18.